Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Hall

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
Neuropsychopharmacology Reports|February 6, 2019
Repeated methamphetamine treatment increases spine density in the nucleus accumbens of serotonin transporter knockout miceYoshiyuki Kasahara, Yasufumi Sakakibara, Takashi Hiratsuka, et al.
The International Journal of Neuroscience|March 2, 2012
Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouseEpolia Ramadan, Lisa Chang, Mei Chen, et al.
Biological Psychiatry|March 6, 2007
Mu (mu) opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasisMartin O Job, Amanda Tang, F Scott Hall, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 13, 2006
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout miceMotoyasu Yamashita, Setsu Fukushima, Hao-wei Shen, et al.
Synapse (New York, N.Y.)|June 21, 2008
Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawalNobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Medical Journal of the Islamic Republic of Iran|June 9, 2025
Biochemical and Histopathological Alterations Induced by TramadolHusam Abazid, Nour Alabbas, Alaa Hammad, et al.
Family Medicine|July 12, 2024
Expanding Access to Contraceptive Services in a Family Medicine Residency Clinic: The Rapid Access to Contraception Clinic ModelErika A Sullivan, Kayla Jordanova, Andrew D Curtin, et al.
Cancer Letters|March 22, 2017
The dopamine D<sub>3</sub> receptor antagonists PG01037, NGB2904, SB277011A, and U99194 reverse ABCG2 transporter-mediated drug resistance in cancer cell linesNoor Hussein, Haneen Amawi, Chandrabose Karthikeyan, et al.
Behavioural Brain Research|July 19, 2021
Metformin reduces oxandrolone- induced depression-like behavior in rats via modulating the expression of IL-1β, IL-6, IL-10 and TNF-αAlaa M Hammad, Yasmeen A Ibrahim, Sawsan I Khdair, et al.
Alcoholism, Clinical and Experimental Research|February 8, 2011
The μ opioid receptor is not involved in ethanol-stimulated dopamine release in the ventral striatum of C57BL/6J miceVorani Ramachandra, Francis Kang, Christine Kim, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
Neuropsychopharmacology Reports|February 6, 2019
Repeated methamphetamine treatment increases spine density in the nucleus accumbens of serotonin transporter knockout miceYoshiyuki Kasahara, Yasufumi Sakakibara, Takashi Hiratsuka, et al.
The International Journal of Neuroscience|March 2, 2012
Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouseEpolia Ramadan, Lisa Chang, Mei Chen, et al.
Biological Psychiatry|March 6, 2007
Mu (mu) opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasisMartin O Job, Amanda Tang, F Scott Hall, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 13, 2006
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout miceMotoyasu Yamashita, Setsu Fukushima, Hao-wei Shen, et al.
Synapse (New York, N.Y.)|June 21, 2008
Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawalNobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Medical Journal of the Islamic Republic of Iran|June 9, 2025
Biochemical and Histopathological Alterations Induced by TramadolHusam Abazid, Nour Alabbas, Alaa Hammad, et al.
Family Medicine|July 12, 2024
Expanding Access to Contraceptive Services in a Family Medicine Residency Clinic: The Rapid Access to Contraception Clinic ModelErika A Sullivan, Kayla Jordanova, Andrew D Curtin, et al.
Cancer Letters|March 22, 2017
The dopamine D<sub>3</sub> receptor antagonists PG01037, NGB2904, SB277011A, and U99194 reverse ABCG2 transporter-mediated drug resistance in cancer cell linesNoor Hussein, Haneen Amawi, Chandrabose Karthikeyan, et al.
Behavioural Brain Research|July 19, 2021
Metformin reduces oxandrolone- induced depression-like behavior in rats via modulating the expression of IL-1β, IL-6, IL-10 and TNF-αAlaa M Hammad, Yasmeen A Ibrahim, Sawsan I Khdair, et al.
Alcoholism, Clinical and Experimental Research|February 8, 2011
The μ opioid receptor is not involved in ethanol-stimulated dopamine release in the ventral striatum of C57BL/6J miceVorani Ramachandra, Francis Kang, Christine Kim, et al.
Pageof 17